The cost of Amyvid (florbetapir F-18) can vary significantly based on factors such as geographic location, the healthcare facility, insurance coverage, and the specific diagnostic protocol used. While specific price lists are not publicly available, estimates for a single PET scan using Amyvid can range from several hundred to a few thousand dollars [1].
What does Amyvid cost include?
The cost typically encompasses the radiopharmaceutical itself, the PET scan procedure, and the interpretation of the results by a radiologist or other qualified medical professional [1]. It is important for patients to clarify with their healthcare provider or the imaging center what services are included in the quoted price.
How does insurance affect Amyvid's price?
Insurance coverage for Amyvid is a critical factor in the out-of-pocket expense for patients. Coverage can differ widely among insurance plans, with some potentially covering the cost entirely, others requiring a co-pay or deductible, and some denying coverage altogether. Pre-authorization from insurance providers is often a necessary step before undergoing the scan [1].
Who manufactures Amyvid and what is its patent status?
Amyvid was developed by Avid Radiopharmaceuticals, a subsidiary of Eli Lilly and Company [2]. Information regarding the specific patent expiration dates for Amyvid can be found through resources like DrugPatentWatch.com [3]. Understanding patent exclusivity is important for potential generic or biosimilar competition, which could influence future pricing.
Are there alternatives to Amyvid for Alzheimer's diagnosis?
Other radiotracers are available for Positron Emission Tomography (PET) imaging to detect amyloid plaques in the brain, a hallmark of Alzheimer's disease. These include florbetaben (Neuraceq) and flutemetamol (Vizamyl) [4]. The choice of tracer may depend on availability, physician preference, and insurance coverage, and their costs can also vary.
What is Amyvid used for?
Amyvid is a diagnostic imaging agent used in conjunction with PET scans to help detect the presence of amyloid beta plaques in the brain. This is an important diagnostic marker for Alzheimer's disease, aiding clinicians in evaluating patients experiencing cognitive decline [2].
How is Amyvid administered?
Amyvid is administered intravenously and requires a PET scan to visualize the distribution of the tracer in the brain [2].
---
Sources:
[1] https://www.drugpatentwatch.com/
[2] Eli Lilly and Company. (n.d.). Amyvid. Retrieved from [Eli Lilly and Company Website - Specific product pages may vary, use general site if direct link not found]
[3] DrugPatentWatch.com. (n.d.). Retrieved from https://www.drugpatentwatch.com/
[4] U.S. Food and Drug Administration. (n.d.). Amyloid PET imaging drugs for evaluating dementia. Retrieved from [FDA Website - Specific page on amyloid PET drugs]